600211 西藏药业
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,004,751994,7911,063,422837,377366,531
投资活动产生之现金流量净额(589,074)354,486(831,884)(561,246)(740,803)
筹资活动产生之现金流量净额(122,623)(732,993)(483,685)(145,367)376,670
汇率变动对现金及现金等价物的影响(22,454)7,4387,04140,107(14,416)
现金及现金等价物净增加/(减少)270,599623,722(245,106)170,872(12,018)
期初现金及现金等价物余额1,305,901682,180927,286756,414768,432
期末现金及现金等价物余额1,576,5001,305,901682,180927,286756,414